Entities / Company
Cystic Fibrosis Foundation.
non-profit organization in the USA
- Reports this week
- 0
- Active events
- 0
- Connections
- 14
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ days-
Prime Medicine, supported by the Cystic Fibrosis Foundation, achieved clinical proof-of-concept for CF treatments and plans to engage the FDA.Some support3 reports2 developments inside
-
Foundation commits $24M for therapy development, led by David Liu and Michael P. Boyle, who is CEO of the Foundation.Some support1 report
-
Cystic Fibrosis Foundation provides up to $24 million in additional funding to Prime Medicine, Inc.Some support1 report
-
Cystic Fibrosis Foundation provided $39 million in funding, while tariffs and onshoring benefit certain AI stocks.Some support1 report
-
Prime Medicine, Inc. sold shares to the Cystic Fibrosis Foundation, with TD Cowen acting as joint book-running manager and filing with the SEC.Some support2 reports
No events began in the chosen period. Widen it, or reset.
History
Events by the month they beganJune 2026
5 events- Prime Medicine, supported by the Cystic Fibrosis Foundation, achieved clinical proof-of-concept for CF treatments and plans to engage the FDA.
- Foundation commits $24M for therapy development, led by David Liu and Michael P. Boyle, who is CEO of the Foundation.
- Cystic Fibrosis Foundation provides up to $24 million in additional funding to Prime Medicine, Inc.
- Cystic Fibrosis Foundation provided $39 million in funding, while tariffs and onshoring benefit certain AI stocks.
- Prime Medicine, Inc. sold shares to the Cystic Fibrosis Foundation, with TD Cowen acting as joint book-running manager and filing with the SEC.